Nav: Home

Diabetes increases the risk of cancer, with a higher risk in women

July 19, 2018

Diabetes is a risk factor for all-site cancer for both men and women, but the increased risk is higher in women than in men, according to a new article in Diabetologia (the journal of the European Association for the Study of Diabetes).

Cancer is the second leading cause of death in the world. It is estimated that 1 in 4 women, and 1 in 3 men, develop cancer during their lifetime. In 2015 there were 17.5 million incident cancer cases and 8.7 million cancer deaths globally, and these figures are expected to increase in the next decades. Diabetes prevalence has also grown rapidly: 415 million adults were reported to have the condition in 2015, with 5 million deaths attributed. In the same year 12% of global health expenditure was spent on diabetes and its complications.

Previous studies have indicated that diabetes is associated with a risk of all-site and some site-specific cancers. For other conditions, such as stroke, coronary heart disease and dementia, there is published evidence (from these same authors) that excess risk of these conditions associated with diabetes is greater in women than in men. This study, conducted by Dr Toshiaki Ohkuma, Dr Sanne Peters and Professor Mark Woodward of the George Institute for Global Health at the University of New South Wales, Sydney, Australia and the University of Oxford, Oxford, UK, assessed whether there are sex differences in the association between diabetes and cancer.

In December 2016, the authors undertook a systematic search in PubMed MEDLINE to identify reports on the links between diabetes and cancer. Additional reports were identified from the reference lists of the relevant studies. Only those cohort studies providing relative risks (RRs) for the association between diabetes and cancer for both women and men were included - studies with data only for one sex were excluded, as were studies that had not adjusted for at least age as a confounder. In total, 107 relevant articles were identified, along with 36 cohorts of individual participant data.

Statistical analysis considered diabetes (types 1 and 2 combined) with all-site cancer events. Additionally, for those cancers that can occur in both sexes, site-specific cancer events were analysed. Relative risks (RRs) for cancer were obtained for those individuals with diabetes versus those without diabetes, for both men and women. The women-to-men ratios of these relative risk ratios (RRRs) were then calculated, to work out the excess risk in women if present.

Data on all-site cancer was available from 47 studies, involving 121 cohorts and 19,239,302 individuals. Women with diabetes had a 27% higher risk of all-site cancer compared to women without diabetes; for men with diabetes the risk was 19% higher than for men without. Calculation of the women-to-men ratio revealed that women with diabetes had a 6% greater excess risk of all-site cancer compared to men with diabetes.

Data on site-specific cancer were available for 50 sites. The women-to-men ratios showed statistically significant higher risks for women with diabetes for kidney (11% higher); oral (13% higher); stomach (14% higher); and leukaemia (15% higher) cancers, compared to men with diabetes. For liver cancer the risk for women with diabetes was 12% lower than for men with diabetes.*

The authors suggest that there are several possible explanations for the excess risk of all-site cancer conferred by diabetes in women. Hyperglycaemia (i.e. heightened blood glucose) may have carcinogenic effects by causing DNA damage - an effect that would be potentially more pronounced in women because historically women were likely to be undertreated, receive less intensive care, or show lower adherence to antidiabetic medication compared to men.

Alternatively, because the average duration of impaired glucose tolerance or impaired fasting glucose has been found to be over 2 years longer in women, they may have more exposure to untreated hyperinsulinaemia (high levels of insulin) in the prediabetic state - hyperinsulinaemia has been found to promote cancer cell proliferation. Another factor that may impact on the lower risk ratio for all-site cancer in men may be the apparent protective effect of diabetes in prostate cancer, a type that affects men only.

The authors also found that diabetes conferred a higher site-specific risk for women than men for oral, stomach and kidney cancers and leukaemia*, but a lower risk for liver cancer. The authors note that the literature around mechanisms underpinning the sex differences in site-specific cancers is scant. However, unmeasured confounding factors specific to each site, for example Helicobacter pylori infection for stomach cancer, and hepatitis virus infection for liver cancer may be involved."

Diabetes has been associated with the risk of all-site, and some site-specific, cancers in several systematic reviews and meta-analyses. Previously, however, there has been no systematic overview of the evidence available that sex differences may impact on this risk. This study confirms that diabetes is indeed a risk factor for all-site cancer in both sexes, but shows also that the effect is stronger in women than in men, and that this increase in risk for women varies with cancer site.

The authors stress "the importance of a sex-specific approach to quantification of the role of diabetes in cancer research, prevention and treatment," and conclude that "further studies are needed to clarify the mechanisms underlying the sex differences in the diabetes-cancer association."
-end-


Diabetologia

Related Diabetes Articles:

The role of vitamin A in diabetes
There has been no known link between diabetes and vitamin A -- until now.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
Type 2 diabetes and obesity -- what do we really know?
Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
New cause of diabetes
Although insulin-producing cells are found in the endocrine tissue of the pancreas, a new mouse study suggests that abnormalities in the exocrine tissue could cause cell non-autonomous effects that promotes diabetes-like symptoms.
The Lancet Diabetes & Endocrinology: Reducing sugar content in sugar-sweetened drinks by 40 percent over 5 years could prevent 1.5 million cases of overweight and obesity in the UK and 300,000 cases of diabetes
A new study published in The Lancet Diabetes & Endocrinology journal suggests that reducing sugar content in sugar sweetened drinks (including fruit juices) in the UK by 40 percent over five years, without replacing them with any artificial sweeteners, could prevent 500,000 cases of overweight and 1 million cases of obesity, in turn preventing around 300,000 cases of type 2 diabetes, over two decades.
Breastfeeding lowers risk of type 2 diabetes following gestational diabetes
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine.

Related Diabetes Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".